← Open Payments lookup

RONNIE POLLARD: Open Payments

NPI 1104871243 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$6,269 in 28 payments from 13 companies in 2025. Trend: 2023 $110 · 2024 $16,203 · 2025 $6,269

Speaker / faculty: $5,288Food & beverage: $981
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.2$5,311
Alkermes, Inc.6$167
Otsuka America Pharmaceutical, Inc.3$155
Axsome Therapeutics, Inc.2$139
Corium, LLC4$117
Janssen Pharmaceuticals, Inc1$112
Neurocrine BioSciences, Inc.2$72
Vanda Pharmaceuticals Inc.2$59
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$57
ABBVIE INC.1$24

Products named: UZEDY, REXULTI, ARISTADA, Auvelity, Azstarys, SPRAVATO, INGREZZA, FANAPT.

Industry payments across TX — which companies pay providers there.